Table 2.
Treatment protocols and treated sites.
| BT-HDR boost 10 Gy | All 57 patients (100%) |
| HT Tref 43 °C/60 min | 32 (56.1%) |
| EBRT | |
| 50 Gy/#2 Gy [EQD2 50.0 Gy] | 3 (5.3%) |
| 45 Gy/#2.25 Gy [EQD2 46.9 Gy] | 19 (33.3%) |
| 42,5 Gy/#2.5 Gy [EQD2 46.0 Gy] | 35 (61.4%) |
| Chemotherapy | |
| Yes | 34 (59.6%) |
| No | 23 (40.4%) |
| All | BT-HDR + HT | BT-HDR alone | |
|---|---|---|---|
| Tumor location (breast) | |||
| Right | 27 (47.4%) | 12 (21.1%) | 15 (26.3%) |
| Left | 30 (52.6%) | 20 (35.1%) | 10 (17.5%) |
| Tumor location (quadrant) | |||
| ULQ | 29 (50.9%) | 18 (31.6%) | 11 (19.3%) |
| UMQ | 6 (10.5%) | 5 (8.8%) | 1 (1.7%) |
| LLQ | 9 (15.8%) | 5 (8.8%) | 4 (7%) |
| LMQ | 8 (14%) | 1 (1.7%) | 7 (12.3%) |
| RA | 5 (8.8%) | 3 (5.3%) | 2 (3.5%) |
| Total | 57 (100%) | 32 (56.1%) | 25 (43.9%) |
Abbreviation: Tref – reference temperature set at 43 °C, ULQ – upper lateral quadrant, UMQ – upper medial quadrant, LLQ – lower lateral quadrant, LMQ – lower medial quadrant, RA – retroareolar.